Protalix BioTherapeutics (PLX) Gross Profit (2010 - 2026)
Protalix BioTherapeutics' quarterly Gross Profit came in at $29.6 million in Q1 2026, up 1432.49% year-on-year from $1.9 million in Q1 2025, and up 557.85% quarter-over-quarter from $4.5 million in Q4 2025.
Protalix BioTherapeutics has reported Gross Profit for 17 years, with the latest figure at $29.6 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 1432.49% year-over-year to $29.6 million; the trailing twelve-month figure through Mar 2026 stood at $53.4 million (up 78.93% YoY), and the FY2025 full-year result was $25.8 million, down 11.45% from the prior year.
- Gross Profit for Q1 2026 stood at $29.6 million, up from $4.5 million in the prior quarter.
- The five-year high for Gross Profit was $29.6 million in Q1 2026, with the low at $1.1 million in Q1 2024.
- Average Gross Profit over 5 years is $9.1 million, with a median of $6.5 million recorded in 2023.
- Year-over-year, Gross Profit plunged 86.11% in 2024 and surged 1432.49% in 2026.
- Tracing PLX's Gross Profit over 5 years: stood at $6.2 million in 2022, then sank by 73.79% to $1.6 million in 2023, then jumped by 779.26% to $14.3 million in 2024, then sank by 68.58% to $4.5 million in 2025, then jumped by 557.85% to $29.6 million in 2026.
- The last three Gross Profit figures came in at $29.6 million (Q1 2026), $4.5 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.62 Mn |
| Mar 31, 2026 | 29.62 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Sep 30, 2025 | 9.53 Mn |
| Sep 30, 2025 | 9.53 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 14.33 Mn |
| Dec 31, 2024 | 14.33 Mn |
| Sep 30, 2024 | 9.58 Mn |
| Sep 30, 2024 | 9.58 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 28.93 Mn |
| Jun 30, 2023 | 28.93 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 4.67 Mn |
| Jun 30, 2022 | 4.67 Mn |
| Mar 31, 2022 | 10.05 Mn |
| Mar 31, 2022 | 10.05 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Sep 30, 2021 | 8.35 Mn |
| Sep 30, 2021 | 8.35 Mn |
| Jun 30, 2021 | 1.69 Mn |
| Jun 30, 2021 | 1.69 Mn |
| Mar 31, 2021 | 6.56 Mn |
| Mar 31, 2021 | 6.56 Mn |
| Dec 31, 2020 | 16.74 Mn |
| Dec 31, 2020 | 16.74 Mn |
| Sep 30, 2020 | 7.92 Mn |
| Sep 30, 2020 | 7.92 Mn |
| Jun 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 9.14 Mn |
| Mar 31, 2020 | 18.22 Mn |
| Mar 31, 2020 | 18.22 Mn |
| Dec 31, 2019 | 11.03 Mn |
| Dec 31, 2019 | 11.03 Mn |
| Sep 30, 2019 | 11.04 Mn |
| Sep 30, 2019 | 11.04 Mn |
| Jun 30, 2019 | 9.55 Mn |
| Jun 30, 2019 | 9.55 Mn |
| Mar 31, 2019 | 8.39 Mn |
| Mar 31, 2019 | 8.39 Mn |
| Dec 31, 2018 | -522,000.00 |
| Dec 31, 2018 | -522,000.00 |
| Sep 30, 2018 | -1.25 Mn |
| Sep 30, 2018 | -1.25 Mn |
| Jun 30, 2018 | -177,000.00 |
| Jun 30, 2018 | -177,000.00 |
| Mar 31, 2018 | 1.63 Mn |
| Mar 31, 2018 | 1.63 Mn |
| Dec 31, 2017 | 915,000.00 |
| Dec 31, 2017 | 915,000.00 |
| Sep 30, 2017 | 1.46 Mn |
| Sep 30, 2017 | 1.46 Mn |
| Jun 30, 2017 | 835,000.00 |
| Jun 30, 2017 | 835,000.00 |
| Mar 31, 2017 | 801,000.00 |
| Mar 31, 2017 | 801,000.00 |
| Dec 31, 2016 | 129,000.00 |
| Dec 31, 2016 | 129,000.00 |
| Sep 30, 2016 | 422,000.00 |
| Sep 30, 2016 | 422,000.00 |
| Jun 30, 2016 | 94,000.00 |
| Jun 30, 2016 | 94,000.00 |
| Mar 31, 2016 | 156,000.00 |
| Mar 31, 2016 | 156,000.00 |
| Sep 30, 2015 | 1.11 Mn |
| Sep 30, 2015 | 1.11 Mn |
| Jun 30, 2015 | 1.11 Mn |
| Jun 30, 2015 | 1.11 Mn |
| Mar 31, 2015 | 1.41 Mn |
| Mar 31, 2015 | 1.41 Mn |
| Mar 31, 2014 | 3.31 Mn |
| Mar 31, 2014 | 3.31 Mn |
| Dec 31, 2013 | -6.52 Mn |
| Dec 31, 2013 | -6.52 Mn |
| Sep 30, 2013 | 1.77 Mn |
| Sep 30, 2013 | 1.77 Mn |
| Jun 30, 2013 | 1.75 Mn |
| Jun 30, 2013 | 1.75 Mn |
| Mar 31, 2013 | 3.00 Mn |
| Mar 31, 2013 | 3.00 Mn |
| Dec 31, 2012 | -1.13 Mn |
| Dec 31, 2012 | -1.13 Mn |
| Sep 30, 2012 | 3.02 Mn |
| Sep 30, 2012 | 3.02 Mn |
| Jun 30, 2012 | 21.98 Mn |
| Jun 30, 2012 | 21.98 Mn |
| Mar 31, 2012 | 2.41 Mn |
| Mar 31, 2012 | 2.41 Mn |
| Dec 31, 2011 | 294,000.00 |
| Dec 31, 2011 | 294,000.00 |
| Sep 30, 2011 | 677,000.00 |
| Sep 30, 2011 | 677,000.00 |
| Jun 30, 2011 | -4.75 Mn |
| Jun 30, 2011 | -4.75 Mn |
| Mar 31, 2011 | 5.22 Mn |
| Mar 31, 2011 | 5.22 Mn |
| Dec 31, 2010 | 3.28 Mn |
| Dec 31, 2010 | 3.28 Mn |
| Sep 30, 2010 | 2.12 Mn |
| Sep 30, 2010 | 2.12 Mn |
| Jun 30, 2010 | 613,000.00 |
| Jun 30, 2010 | 613,000.00 |